HHC
AGIO icon

Hutchin Hill Capital’s Agios Pharmaceuticals AGIO Stock Holding History

Hutchin Hill Capital’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-25,000
Closed -$699K – 512
2013
Q3 		$699K Buy
+25,000
New +$690K 0.06% 242

Other funds holding AGIO

TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Hutchin Hill Capital's AGIO Position: Q4 2013 in Review

Hutchin Hill Capital sold out of Agios Pharmaceuticals (AGIO) in Q4 2013, closing a stake of 25,000 shares — an estimated $699K sold.

Hutchin Hill Capital first reported a position in AGIO in Q3 2013 and held it in 1 quarter. The position peaked at $699K in Q3 2013. 66 funds tracked by Wall St. Rank hold AGIO as of Q4 2013.

  • Hutchin Hill Capital reported no remaining Agios Pharmaceuticals position as of Q4 2013 after selling out during the quarter.
  • Hutchin Hill Capital sold 25,000 Agios Pharmaceuticals shares in Q4 2013, an estimated $699K.
  • Hutchin Hill Capital first reported a position in Agios Pharmaceuticals in Q3 2013 and held it in 1 quarter.
  • Hutchin Hill Capital's Agios Pharmaceuticals position peaked at $699K in Q3 2013.
  • 66 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2013.

Based on Hutchin Hill Capital's 13F filing for Q4 2013, filed 14 Feb 2014.